| Revision as of 02:27, 12 July 2004 editGuanabot (talk | contribs)32,249 editsm Guanaco - Robot bypassing redirects: UK← Previous edit | Revision as of 23:49, 23 July 2004 edit undoMykhal (talk | contribs)Extended confirmed users5,566 edits structure formula added, summary formula correctedNext edit → | ||
| Line 1: | Line 1: | ||
| '''Escitalopram oxalate''' (also known as '''Lexapro'''<sup>TM</sup> and '''Cipralex'''<sup>TM</sup>) is a medication developed by the ] pharmaceutical company ], that acts as a ] or SSRI. It is typically used as an ] to treat ] associated with ]s although also may be used in the treatment of ] and ]. | ]'''Escitalopram oxalate''' (also known as '''Lexapro'''<sup>TM</sup> and '''Cipralex'''<sup>TM</sup>) is a medication developed by the ] pharmaceutical company ], that acts as a ] or SSRI. It is typically used as an ] to treat ] associated with ]s although also may be used in the treatment of ] and ]. | ||
| Escitalopram is the pure S-] (single ]) of the ] bicyclic phthalane derivative citalopram. Escitalopram oxalate is designated S-(+)-1--1-( ''p'' -fluorophenyl)-5-phthalancarbonitrile oxalate with the molecular formula: | Escitalopram is the pure S-] (single ]) of the ] bicyclic phthalane derivative citalopram. Escitalopram oxalate is designated S-(+)-1--1-( ''p'' -fluorophenyl)-5-phthalancarbonitrile oxalate with the molecular formula: | ||
| <blockquote>C |
<blockquote>C<sub>20</sub>H<sub>22</sub>FN<sub>2</sub>O<sup>+</sup> C<sub>2</sub>HO<sub>4</sub><sup>-</sup></blockquote> | ||
| and the molecular weight is 414.40. | and the molecular weight is 414.40. | ||
Revision as of 23:49, 23 July 2004
Escitalopram oxalate (also known as Lexapro and Cipralex) is a medication developed by the Danish pharmaceutical company Lundbeck, that acts as a selective serotonin reuptake inhibitor or SSRI. It is typically used as an antidepressant to treat depression associated with mood disorders although also may be used in the treatment of body dysmorphic disorder and anxiety.
Escitalopram is the pure S-enantiomer (single isomer) of the racemic bicyclic phthalane derivative citalopram. Escitalopram oxalate is designated S-(+)-1--1-( p -fluorophenyl)-5-phthalancarbonitrile oxalate with the molecular formula:
C20H22FN2O C2HO4
and the molecular weight is 414.40.
Escitalopram oxalate is derived from the drug citalopram which is made up of two mirror-image isomers, only one of which is thought to be an effective medication. Lundbeck has split the isomers apart, taken the active isomer and has licensed it as the new drug 'escitalopram'.
It is notable that escitalopram was released shortly before the patent for citalopram was due to expire. The expiration of a patent means other companies can legally produce cheaper generic versions. Escitalopram is subject to a new patent. Critics have argued that escitalopram, and the subsequent marketing campaign to persuade mental health professionals to prescribe it, is a cynical ploy to promote sales of a virtually identical but considerably more expensive drug. In defence of the new drug, Lundbeck have claimed that the drug has additional benefits over the older citalopram and other antidepressant drugs on the market.
Externals links
Pharmacological information and studies on escitalopram:
Lundbeck official websites for escitalopram under their trade names Cipralex and Lexapro:
"'Radical' drug criticised as only a commercial device" article from UK paper, The Guardian:
"Lexapro feedback" page from Depression Blog:
Category: